These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14114175)

  • 21. EXPERIENCE WITH ATROMID IN VARIOUS HYPERCHOLESTEROLAEMIC STATES AND DIABETES MELLITUS.
    DEMOWBRAY RR
    J Atheroscler Res; 1963; 3():689-93. PubMed ID: 14100913
    [No Abstract]   [Full Text] [Related]  

  • 22. THE EFFECT OF ATROMID, AN ORALLY ACTIVE ANDROSTERONE ON SERUM LIPIDS IN NORMAL, HYPERCHOLESTEROLAEMIC AND HYPERLIPAEMIC SUBJECTS.
    PRIOR IA; CAMPBELL DG
    N Z Med J; 1963 Nov; 62():538-44. PubMed ID: 14081103
    [No Abstract]   [Full Text] [Related]  

  • 23. ATROMID-S AND ATROMID.
    OLIVER MF
    Practitioner; 1964 Mar; 192():424-30. PubMed ID: 14130844
    [No Abstract]   [Full Text] [Related]  

  • 24. THE EFFECT OF ETHYL CHLOROPHENOXYISOBUTYRATE ON THE BINDING BETWEEN TRIIODOTHYRONINE AND PROTEIN.
    MOGENSEN EF
    J Atheroscler Res; 1963; 3():415-7. PubMed ID: 14100882
    [No Abstract]   [Full Text] [Related]  

  • 25. Triparanol-induced desmoterol accumulation in clofibrate-effected hypocholesterolemia.
    Arnold A; Powers LG; McAuliff JP
    Atherosclerosis; 1974; 20(2):401-4. PubMed ID: 4416741
    [No Abstract]   [Full Text] [Related]  

  • 26. THE RESPONSE OF HYPERLIPOPROTEINEMIAS TO ATROMID AND ETHYL CHLOROPHENOXYISOBUTYRATE.
    STRISOWER EH
    J Atheroscler Res; 1963; 3():445-53. PubMed ID: 14100885
    [No Abstract]   [Full Text] [Related]  

  • 27. [EFFECT OF DEHYDROEPIANDROSTERONE AND ATROMID ON SERUM LIPIDS IN PATIENTS WITH HYPERCHOLESTEREMIA OR HYPERTRIGLYCERIDEMIA].
    FELT V; STARKA L; BEDNAR J
    Cas Lek Cesk; 1965 Feb; 104():186-9. PubMed ID: 14310921
    [No Abstract]   [Full Text] [Related]  

  • 28. Xanthomatosis, hyperlipoproteinaemia (type II, Fredrickson), gout, cardiac infarction.
    Storey GO
    Proc R Soc Med; 1971 Jan; 64(1):59-60. PubMed ID: 5551460
    [No Abstract]   [Full Text] [Related]  

  • 29. STUDIES ON LOW-DENSITY LIPOPROTEIN TURNOVER IN RELATION TO ATROMID THERAPY.
    WALTON KW; SCOTT PJ; VERRIERJONES J; FLETCHER RF; WHITEHEAD T
    J Atheroscler Res; 1963; 3():396-414. PubMed ID: 14100881
    [No Abstract]   [Full Text] [Related]  

  • 30. Xanthomatosis and hyperlipoproteinemia; a review.
    Polano MK
    Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
    [No Abstract]   [Full Text] [Related]  

  • 31. OBSERVATIONS ON THE POSSIBILITY OF INFLUENCING HYPERLIPAEMIA BY DIFFERENT DRUGS.
    RETSAGI G; KELLER L; GERO S
    Gerontol Clin (Basel); 1964; 6():22-7. PubMed ID: 14105115
    [No Abstract]   [Full Text] [Related]  

  • 32. A TWO-YEAR EVALUATION OF "ATROMID" FOR THE CONTROL OF ABNORMAL BLOOD LIPID LEVELS.
    PEAK HJ; MITCHELL AS; JOSE AD
    Med J Aust; 1965 Jul; 2(5):192-4. PubMed ID: 14348329
    [No Abstract]   [Full Text] [Related]  

  • 33. ACTION OF ATROMID ON SERUM LIPIDS AND ON BETA-LIPOPROTEIN LIPIDS AND PROTEIN.
    CRAMER K
    J Atheroscler Res; 1963; 3():500-8. PubMed ID: 14100890
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements.
    OLIVER MF; ROBERTS SD; HAYES D; PANTRIDGE JF; SUZMAN MM; BERSOHN I
    Lancet; 1963 Jan; 1(7273):143-4. PubMed ID: 13940003
    [No Abstract]   [Full Text] [Related]  

  • 35. THE EFFECTS OF ATROMID ON THE ALPHA-BETA-LIPOPROTEIN RATIO IN CORONARY DISEASE.
    KERNOHAN RJ; NEELY RA
    J Atheroscler Res; 1963; 3():518-24. PubMed ID: 14100892
    [No Abstract]   [Full Text] [Related]  

  • 36. BETA-LIPOPROTEIN, LIPOPROTEIN LIPASE AND ATROMID.
    HOOD B; BEDDING P; CARLANDER B
    J Atheroscler Res; 1963; 3():509-17. PubMed ID: 14100891
    [No Abstract]   [Full Text] [Related]  

  • 37. THE EFFECT OF SF 20-10-5 CONCENTRATION CHANGES INDUCED BY ETHYL CHLOROPHENOXYISOBUTYRATE ON HIGH-DENSITY LIPOPROTEIN LIPID COMPOSITION.
    STRISOWER EH; NICHOLS AV; LINDGREN FT; SMITH L
    J Lab Clin Med; 1965 May; 65():748-55. PubMed ID: 14281371
    [No Abstract]   [Full Text] [Related]  

  • 38. Heterogeneity on familial hyperlipoproteinemia type II on the basis of fasting plasma triglyceride-cholesterol ratio and plasma cholesterol response to ethyl p-chlorophenoxyisobutyrate.
    Davignon J; Aubry F; Noël C; Lapierre Y; Lafortune M
    Rev Can Biol; 1971 Dec; 30(4):307-18. PubMed ID: 5135408
    [No Abstract]   [Full Text] [Related]  

  • 39. [BLOOD STEROLS IN XANTHOMATOUS FAMILIAL HYPERCHOLESTEROLEMIA. CHROMATOGRAPHIC ANALYSIS].
    BEAUMONT JL; CLAUDE JR
    Rev Fr Etud Clin Biol; 1964 Oct; 9():859-62. PubMed ID: 14226826
    [No Abstract]   [Full Text] [Related]  

  • 40. [CRITICAL REVIEW OF THE CLINICAL, BIOLOGICAL AND ETIOLOGICAL ASPECTS OF HYPERLIPEMIA OR HYPERGLYCERIDEMIA].
    DE GENNES JL; BOUCHON JP; LAUDAT P; TRUFFERT J
    Rev Atheroscler; 1964; 6():7-36. PubMed ID: 14169668
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.